Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
6 Patents
#142 in Cambridge
#2,680 in United Kingdom
Cypralis Limited
Forward Citations = 2
19 inventors:
Cypralis Limited
Calculating rank
% Expired Patents = 50.0
EPO Patents = 5
Forward Citations = 2
Loading Chart...
Loading Chart...
19 inventors (with patents filed for the assignee):
Richard L Mackman (4 out of 96 patents)
Petr Jansa (4 out of 27 patents)
Caroline Aciro (4 out of 9 patents)
4. David Kenneth Dean (4 out of 9 patents)
5. Adrian John Highton (4 out of 8 patents)
6. Andrew John Keats (4 out of 11 patents)
7. Linos Lazarides (4 out of 18 patents)
8. Karine G Poullennec (4 out of 11 patents)
9. Victoria Alexandra Steadman (4 out of 16 patents)
10. Adam James Schrier (4 out of 23 patents)
11. Dustin S Siegel (4 out of 58 patents)
12. Neil Andrew Dunbar (3 out of 6 patents)
13. Simon Neil Pettit (3 out of 23 patents)
14. Kapil Kumar Karki (3 out of 13 patents)
15. Rhonan Lee Ford (2 out of 4 patents)
6 patents:
Company Overview
Cypralis is a leading biotechnology company focused on the discovery and development of novel therapeutics for the treatment of serious diseases. With a focus on targeting protein misfolding diseases, Cypralis is developing a pipeline of small molecule drugs with the potential to address significant unmet medical needs. Through strategic partnerships and collaborations, Cypralis aims to bring innovative therapies to patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cypralis Limited. Retrieved from https://idiyas.com/company/cypralis
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]